Market revenue in 2023 | USD 141.8 million |
Market revenue in 2030 | USD 322.1 million |
Growth rate | 12.4% (CAGR from 2023 to 2030) |
Largest segment | Oligonucleotide synthesis |
Fastest growing segment | Gene Synthesis |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oligonucleotide Synthesis, Gene Synthesis |
Key market players worldwide | Thermo Fisher Scientific Inc, Twist Bioscience Corp, Codexis Inc, LGC Group, Eurofins Scientific SE, Genscript Biotech Corp Class H, Bioneer, IBA Lifesciences, Danaher Corp, Quintarabio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna synthesis market will help companies and investors design strategic landscapes.
Oligonucleotide synthesis was the largest segment with a revenue share of 55.57% in 2023. Horizon Databook has segmented the Latin America dna synthesis market based on oligonucleotide synthesis, gene synthesis covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America dna synthesis market, including forecasts for subscribers. This continent databook contains high-level insights into Latin America dna synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account